1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global 23-valent Pneumococcal Vaccine Consumption 2016-2026
2.1.2 23-valent Pneumococcal Vaccine Consumption CAGR by Region
2.2 23-valent Pneumococcal Vaccine Segment by Type
2.2.1 Single Dose Vial
2.2.2 Pre-filled Syringe
2.3 23-valent Pneumococcal Vaccine Sales by Type
2.3.1 Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global 23-valent Pneumococcal Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global 23-valent Pneumococcal Vaccine Sale Price by Type (2016-2021)
2.4 23-valent Pneumococcal Vaccine Segment by Application
2.4.1 Chronic Cardiovascular Disease
2.4.2 Chronic Lung Disease
2.4.3 Chronic Liver Disease
2.4.4 People Living with Hiv
2.4.5 Leukemia
2.4.6 Lymphoma
2.4.7 Multiple Myeloma
2.4.8 General Malignancy
2.4.9 Chronic Kidney Disease
2.4.10 Other
2.5 23-valent Pneumococcal Vaccine Sales by Application
2.5.1 Global 23-valent Pneumococcal Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global 23-valent Pneumococcal Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global 23-valent Pneumococcal Vaccine Sale Price by Application (2016-2021)
3 Global 23-valent Pneumococcal Vaccine by Company
3.1 Global 23-valent Pneumococcal Vaccine Sales Market Share by Company
3.1.1 Global 23-valent Pneumococcal Vaccine Sales by Company (2019-2021)
3.1.2 Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2019-2021)
3.2 Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company
3.2.1 Global 23-valent Pneumococcal Vaccine Revenue by Company (2019-2021)
3.2.2 Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global 23-valent Pneumococcal Vaccine Sale Price by Company
3.4 Global Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers 23-valent Pneumococcal Vaccine Product Location Distribution
3.4.2 Players 23-valent Pneumococcal Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 23-valent Pneumococcal Vaccine by Region
4.1 Global 23-valent Pneumococcal Vaccine by Region
4.1.1 Global 23-valent Pneumococcal Vaccine Sales by Region
4.1.2 Global 23-valent Pneumococcal Vaccine Revenue by Region
4.2 Americas 23-valent Pneumococcal Vaccine Sales Growth
4.3 APAC 23-valent Pneumococcal Vaccine Sales Growth
4.4 Europe 23-valent Pneumococcal Vaccine Sales Growth
4.5 Middle East & Africa 23-valent Pneumococcal Vaccine Sales Growth
5 Americas
5.1 Americas 23-valent Pneumococcal Vaccine Sales by Country
5.1.1 Americas 23-valent Pneumococcal Vaccine Sales by Country (2016-2021)
5.1.2 Americas 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021)
5.2 Americas 23-valent Pneumococcal Vaccine Sales by Type
5.3 Americas 23-valent Pneumococcal Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC 23-valent Pneumococcal Vaccine Sales by Region
6.1.1 APAC 23-valent Pneumococcal Vaccine Sales by Region (2016-2021)
6.1.2 APAC 23-valent Pneumococcal Vaccine Revenue by Region (2016-2021)
6.2 APAC 23-valent Pneumococcal Vaccine Sales by Type
6.3 APAC 23-valent Pneumococcal Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe 23-valent Pneumococcal Vaccine by Country
7.1.1 Europe 23-valent Pneumococcal Vaccine Sales by Country (2016-2021)
7.1.2 Europe 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021)
7.2 Europe 23-valent Pneumococcal Vaccine Sales by Type
7.3 Europe 23-valent Pneumococcal Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa 23-valent Pneumococcal Vaccine by Country
8.1.1 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type
8.3 Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 23-valent Pneumococcal Vaccine Distributors
10.3 23-valent Pneumococcal Vaccine Customer
11 Global 23-valent Pneumococcal Vaccine Market Forecast
11.1 Global 23-valent Pneumococcal Vaccine Forecast by Region
11.1.1 Global 23-valent Pneumococcal Vaccine Forecast by Regions (2021-2026)
11.2.2 Global 23-valent Pneumococcal Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global 23-valent Pneumococcal Vaccine Forecast by Type
11.7 Global 23-valent Pneumococcal Vaccine Forecast by Application
12 Key Players Analysis
12.1 Merck
12.1.1 Merck Company Information
12.1.2 Merck 23-valent Pneumococcal Vaccine Product Offered
12.1.3 Merck 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Merck Main Business Overview
12.1.5 Merck Latest Developments
12.2 Sanofipasteur
12.2.1 Sanofipasteur Company Information
12.2.2 Sanofipasteur 23-valent Pneumococcal Vaccine Product Offered
12.2.3 Sanofipasteur 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Sanofipasteur Main Business Overview
12.2.5 Sanofipasteur Latest Developments
12.3 CDIBP
12.3.1 CDIBP Company Information
12.3.2 CDIBP 23-valent Pneumococcal Vaccine Product Offered
12.3.3 CDIBP 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 CDIBP Main Business Overview
12.3.5 CDIBP Latest Developments
12.4 Kexing Bio
12.4.1 Kexing Bio Company Information
12.4.2 Kexing Bio 23-valent Pneumococcal Vaccine Product Offered
12.4.3 Kexing Bio 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Kexing Bio Main Business Overview
12.4.5 Kexing Bio Latest Developments
12.5 Changsheng Bio-Technology
12.5.1 Changsheng Bio-Technology Company Information
12.5.2 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Offered
12.5.3 Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Changsheng Bio-Technology Main Business Overview
12.5.5 Changsheng Bio-Technology Latest Developments
12.6 Huaan Science and Technology Innovation
12.6.1 Huaan Science and Technology Innovation Company Information
12.6.2 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Offered
12.6.3 Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Huaan Science and Technology Innovation Main Business Overview
12.6.5 Huaan Science and Technology Innovation Latest Developments
…
13 Research Findings and Conclusion
List of TablesTable 1. 23-valent Pneumococcal Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Single Dose Vial
Table 3. Major Players of Pre-filled Syringe
Table 4. Global 23-valent Pneumococcal Vaccine Sales by Type (2016-2021) & (K Units)
Table 5. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 6. Global 23-valent Pneumococcal Vaccine Revenue by Type (2016-2021) & ($ million)
Table 7. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2016-2021)
Table 8. Global 23-valent Pneumococcal Vaccine Sale Price by Type (2016-2021)
Table 9. Global 23-valent Pneumococcal Vaccine Sales by Application (2016-2021) & (K Units)
Table 10. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 11. Global 23-valent Pneumococcal Vaccine Value by Application (2016-2021)
Table 12. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application (2016-2021)
Table 13. Global 23-valent Pneumococcal Vaccine Sale Price by Application (2016-2021)
Table 14. Global 23-valent Pneumococcal Vaccine Sales by Company (2019-2021) & (K Units)
Table 15. Global 23-valent Pneumococcal Vaccine Sales Market Share by Company (2019-2021)
Table 16. Global 23-valent Pneumococcal Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 17. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company (2019-2021)
Table 18. Global 23-valent Pneumococcal Vaccine Sale Price by Company (2019-2021)
Table 19. Key Manufacturers 23-valent Pneumococcal Vaccine Producing Area Distribution and Sales Area
Table 20. Players 23-valent Pneumococcal Vaccine Products Offered
Table 21. 23-valent Pneumococcal Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global 23-valent Pneumococcal Vaccine Sales by Region (2016-2021) (K Units)
Table 25. Global 23-valent Pneumococcal Vaccine Sales Market Share by Region (2016-2021)
Table 26. Global 23-valent Pneumococcal Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2016-2021)
Table 28. Americas 23-valent Pneumococcal Vaccine Sales by Country (2016-2021) & (K Units)
Table 29. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 30. Americas 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 32. Americas 23-valent Pneumococcal Vaccine Sales by Type (2016-2021) & (K Units)
Table 33. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 34. Americas 23-valent Pneumococcal Vaccine Sales by Application (2016-2021) & (K Units)
Table 35. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 36. APAC 23-valent Pneumococcal Vaccine Sales by Region (2016-2021) & (K Units)
Table 37. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region (2016-2021)
Table 38. APAC 23-valent Pneumococcal Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Region (2016-2021)
Table 40. APAC 23-valent Pneumococcal Vaccine Sales by Type (2016-2021) & (K Units)
Table 41. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 42. APAC 23-valent Pneumococcal Vaccine Sales by Application (2016-2021) & (K Units)
Table 43. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 44. Europe 23-valent Pneumococcal Vaccine Sales by Country (2016-2021) & (K Units)
Table 45. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 46. Europe 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 48. Europe 23-valent Pneumococcal Vaccine Sales by Type (2016-2021) & (K Units)
Table 49. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 50. Europe 23-valent Pneumococcal Vaccine Sales by Application (2016-2021) & (K Units)
Table 51. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa 23-valent Pneumococcal Vaccine Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of 23-valent Pneumococcal Vaccine
Table 61. Key Application and Potential Industries of 23-valent Pneumococcal Vaccine
Table 62. Key Challenges of 23-valent Pneumococcal Vaccine
Table 63. Key Trends of 23-valent Pneumococcal Vaccine
Table 64. 23-valent Pneumococcal Vaccine Distributors List
Table 65. 23-valent Pneumococcal Vaccine Customer List
Table 66. Global 23-valent Pneumococcal Vaccine Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global 23-valent Pneumococcal Vaccine Consumption Market Forecast by Region
Table 68. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas 23-valent Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC 23-valent Pneumococcal Vaccine Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC 23-valent Pneumococcal Vaccine Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe 23-valent Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global 23-valent Pneumococcal Vaccine Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 80. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global 23-valent Pneumococcal Vaccine Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global 23-valent Pneumococcal Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 84. Global 23-valent Pneumococcal Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global 23-valent Pneumococcal Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 86. Merck Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 87. Merck 23-valent Pneumococcal Vaccine Product Offered
Table 88. Merck 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 89. Merck Main Business
Table 90. Merck Latest Developments
Table 91. Sanofipasteur Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 92. Sanofipasteur 23-valent Pneumococcal Vaccine Product Offered
Table 93. Sanofipasteur 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 94. Sanofipasteur Main Business
Table 95. Sanofipasteur Latest Developments
Table 96. CDIBP Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 97. CDIBP 23-valent Pneumococcal Vaccine Product Offered
Table 98. CDIBP 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 99. CDIBP Main Business
Table 100. CDIBP Latest Developments
Table 101. Kexing Bio Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 102. Kexing Bio 23-valent Pneumococcal Vaccine Product Offered
Table 103. Kexing Bio 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 104. Kexing Bio Main Business
Table 105. Kexing Bio Latest Developments
Table 106. Changsheng Bio-Technology Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 107. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Product Offered
Table 108. Changsheng Bio-Technology 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 109. Changsheng Bio-Technology Main Business
Table 110. Changsheng Bio-Technology Latest Developments
Table 111. Huaan Science and Technology Innovation Basic Information, 23-valent Pneumococcal Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 112. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Product Offered
Table 113. Huaan Science and Technology Innovation 23-valent Pneumococcal Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 114. Huaan Science and Technology Innovation Main Business
Table 115. Huaan Science and Technology Innovation Latest Developments
List of Figures
Figure 1. Picture of 23-valent Pneumococcal Vaccine
Figure 2. 23-valent Pneumococcal Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global 23-valent Pneumococcal Vaccine Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global 23-valent Pneumococcal Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. 23-valent Pneumococcal Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Single Dose Vial
Figure 10. Product Picture of Pre-filled Syringe
Figure 11. Global 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 12. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Type (2016-2021)
Figure 13. 23-valent Pneumococcal Vaccine Consumed in Chronic Cardiovascular Disease
Figure 14. Global 23-valent Pneumococcal Vaccine Market: Chronic Cardiovascular Disease (2016-2021) & (K Units)
Figure 15. 23-valent Pneumococcal Vaccine Consumed in Chronic Lung Disease
Figure 16. Global 23-valent Pneumococcal Vaccine Market: Chronic Lung Disease (2016-2021) & (K Units)
Figure 17. 23-valent Pneumococcal Vaccine Consumed in Chronic Liver Disease
Figure 18. Global 23-valent Pneumococcal Vaccine Market: Chronic Liver Disease (2016-2021) & (K Units)
Figure 19. 23-valent Pneumococcal Vaccine Consumed in People Living with Hiv
Figure 20. Global 23-valent Pneumococcal Vaccine Market: People Living with Hiv (2016-2021) & (K Units)
Figure 21. 23-valent Pneumococcal Vaccine Consumed in Leukemia
Figure 22. Global 23-valent Pneumococcal Vaccine Market: Leukemia (2016-2021) & (K Units)
Figure 23. 23-valent Pneumococcal Vaccine Consumed in Lymphoma
Figure 24. Global 23-valent Pneumococcal Vaccine Market: Lymphoma (2016-2021) & (K Units)
Figure 25. 23-valent Pneumococcal Vaccine Consumed in Multiple Myeloma
Figure 26. Global 23-valent Pneumococcal Vaccine Market: Multiple Myeloma (2016-2021) & (K Units)
Figure 27. 23-valent Pneumococcal Vaccine Consumed in General Malignancy
Figure 28. Global 23-valent Pneumococcal Vaccine Market: General Malignancy (2016-2021) & (K Units)
Figure 29. 23-valent Pneumococcal Vaccine Consumed in Chronic Kidney Disease
Figure 30. Global 23-valent Pneumococcal Vaccine Market: Chronic Kidney Disease (2016-2021) & (K Units)
Figure 31. 23-valent Pneumococcal Vaccine Consumed in Other
Figure 32. Global 23-valent Pneumococcal Vaccine Market: Other (2016-2021) & (K Units)
Figure 33. Global 23-valent Pneumococcal Vaccine Sales Market Share by Application (2016-2021)
Figure 34. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Application in 2020
Figure 35. 23-valent Pneumococcal Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 36. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Company in 2020
Figure 37. Global 23-valent Pneumococcal Vaccine Sales Market Share by Regions (2016-2021)
Figure 38. Global 23-valent Pneumococcal Vaccine Revenue Market Share by Region in 2020
Figure 39. Americas 23-valent Pneumococcal Vaccine Sales 2016-2021 (K Units)
Figure 40. Americas 23-valent Pneumococcal Vaccine Revenue 2016-2021 ($ Millions)
Figure 41. APAC 23-valent Pneumococcal Vaccine Sales 2016-2021 (K Units)
Figure 42. APAC 23-valent Pneumococcal Vaccine Revenue 2016-2021 ($ Millions)
Figure 43. Europe 23-valent Pneumococcal Vaccine Sales 2016-2021 (K Units)
Figure 44. Europe 23-valent Pneumococcal Vaccine Revenue 2016-2021 ($ Millions)
Figure 45. Middle East & Africa 23-valent Pneumococcal Vaccine Sales 2016-2021 (K Units)
Figure 46. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue 2016-2021 ($ Millions)
Figure 47. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2020
Figure 48. Americas 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2020
Figure 49. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 50. Americas 23-valent Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 51. United States 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 52. Canada 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 53. Mexico 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 54. Brazil 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 55. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Region in 2020
Figure 56. APAC 23-valent Pneumococcal Vaccine Revenue Market Share by Regions in 2020
Figure 57. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 58. APAC 23-valent Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 59. China 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Japan 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 61. Korea 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 62. Southeast Asia 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 63. India 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 64. Australia 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 65. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2020
Figure 66. Europe 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2020
Figure 67. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 68. Europe 23-valent Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 69. Germany 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 70. France 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 71. UK 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 72. Italy 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 73. Russia 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 74. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Country in 2020
Figure 75. Middle East & Africa 23-valent Pneumococcal Vaccine Revenue Market Share by Country in 2020
Figure 76. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Type in 2020
Figure 77. Middle East & Africa 23-valent Pneumococcal Vaccine Sales Market Share by Application in 2020
Figure 78. Egypt 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 79. South Africa 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 80. Israel 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 81. Turkey 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 82. GCC Country 23-valent Pneumococcal Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
【免責事項】
https://www.globalresearch.jp/disclaimer